New funding call open
We have six Industrial Biotechnology Seeding Catalyst Awards (IBSCA) available. Each award is up to £25,000, funded at full economic cost for projects of up to 3-months duration. There is no obligation to have an industry partner or industry funding. These awards will fund direct costs only, at 100% FEC. This includes travel and salaries, but not estate costs or overheads.
All projects must be completed, reported upon and invoiced for no later than February 28th 2018. This date is not negotiable, and if not met, monies cannot be transferred.
The closing date for applications is September 30th, but applications will be reviewed as soon as they are submitted. We will aim to give a decision within 3 weeks of application being received, and no later than October 31st for applications received on the deadline.
Eligible activities for funding include (but are not be limited to):
– Proof-of-concept studies
– Access to scale-up and facilities to demonstrate commercial potential of an idea/technology
– Development and surveillance of market intelligence including IP landscape analysis/freedom to operate, regulatory analysis, development of exploitation plans
– Development of market or product demonstrators.
The projects should align with the remit of BioProNET [the use of cells and their components (that is, bioprocessing) to produce biologics, which we define as products that are composed of proteins (such as antibodies), peptides, RNA, DNA or vaccines] as well as the aims and objectives of the IBSCA call, which are:
1. To develop and progress ideas and technology within the scope and remit of BioProNET and the call along the technology readiness level (TRL) pathway
2. To further develop previously funded BioProNET PoC and BIV projects
3. Increase business—academic engagement on innovation activities relating to challenge areas identified by the BioProNET community
4. Foster collaboration between SMEs, larger, more established companies up the value chain and academics within the remit of BioProNET
5. Accelerate translational development of innovations and technologies by supporting work that will forward the development of early TRL projects
6. To support multi- and inter- disciplinary research around BioProNET challenge areas
7. Encourage and secure/leverage increased UK business investment in R&D and improved R&D capability and capacity in bioprocessing
8. Generate data and information that supports applications for larger grant funding
9. Provide support for academics to apply and translate their ideas and science to industrially relevant challenges within any societal, environmental, economic, regulatory or political constraints or opportunities for their work